|
Cardiovascular Research Foundation
|
Director, Translational Therapeutics
|
New York, NY
|
$480000
|
H-1B
|
Jul 29, 2025
|
|
HOFFMANN-LA ROCHE INC.
|
VP, TRANSLATIONAL & EXPERIMENTAL MEDICINE HEAD, IN
|
NUTLEY, NJ
|
$360000
|
H-1B
|
Jul 26, 2011
|
|
Regeneron Genetics Center, LLC
|
Sr Director Translational Genetics
|
Tarrytown, NY
|
$309650
|
H-1B
|
Jan 14, 2026
|
|
Mesoblast, Inc.
|
Sr. Vice President of Translational Development
|
New York, NY
|
$300000
|
E-3
|
Jan 26, 2022
|
|
CELGENE CORPORATION
|
VICE PRESIDENT - TRANSLATIONAL MEDICINE
|
SUMMIT, NJ
|
$300000
- $315000
|
H-1B
|
Oct 7, 2009
|
|
Takeda Development Center Americas, Inc.
|
Medical Director, Clinical and Translational Scie…
|
Cambridge, MA
|
$295830
|
H-1B
|
Apr 2, 2026
|
|
ISS TRANSLATORS, INC.
|
TECHNICAL TRANSLATION INSTRUCTOR
|
TORRANCE, CA
|
$295560
|
H-1B
|
Jun 4, 2009
|
|
BOEHRINGER INGELHEIM PHARMACEUTICALS, I…
|
ED, Translational Medicine & Clinical Pharmacolog…
|
Ridgefield, CT
|
$286000
- $329600
|
H-1B
|
May 31, 2023
|
|
Regeneron Genetics Center, LLC
|
Sr Director Translational Genetics
|
Tarrytown, NY
|
$280000
|
H-1B
|
Apr 30, 2024
|
|
BOEHRINGER INGELHEIM PHARMACEUTICALS, I…
|
Principal Translational Medicine Expert
|
Ridgefield, CT
|
$255779
- $295332
|
H-1B
|
Mar 8, 2021
|
|
ASTRAZENECA PHARMACEUTICALS LP
|
Associate Director Physician, Translational Scien…
|
Waltham, MA
|
$250000
|
H-1B
|
Mar 18, 2020
|
|
BOEHRINGER INGELHEIM PHARMACEUTICALS, I…
|
Principal Translational Medicine Expert
|
Ridgefield, CT
|
$248329
- $332593
|
H-1B
|
Feb 14, 2020
|
|
Genentech, Inc.
|
Senior Principal Scientist Translational Medicine
|
South San Francisco, CA
|
$247272
- $316440
|
H-1B
|
Apr 21, 2023
|
|
SELECTA BIOSCIENCES, INC.
|
NANOTECHNOLOGY TRANSLATION OFFICER
|
WATERTOWN, MA
|
$225000
- $325000
|
H-1B
|
Aug 1, 2013
|
|
Kite Pharma Inc.
|
Executive Director, Translational Medicine
|
Santa Monica, CA
|
$221478
- $387600
|
H-1B
|
Feb 18, 2025
|
|
Modalis Therapeutics Inc.
|
Director, Translational Research
|
Waltham, MA
|
$220000
|
H-1B
|
Mar 17, 2022
|
|
Modalis Therapeutics Inc.
|
Director, Translational Research
|
Queens, NY
|
$220000
|
H-1B
|
Mar 28, 2022
|
|
Autobahn Therapeutics, Inc. (f/k/a Llam…
|
Executive Director, Translational Neuroscience
|
San Diego, CA
|
$215000
|
H-1B
|
Feb 6, 2020
|
|
Mesoblast, Inc.
|
Vice President of Translational Development
|
New York, NY
|
$206000
|
E-3
|
Dec 17, 2019
|
|
Genetix Biotherapeutics Inc.
|
Director, Translational Biomarkers
|
Somerville, MA
|
$205000
- $254000
|
H-1B
|
Nov 24, 2025
|
|
Novo Nordisk Research & Development US,…
|
Principal Scientist - Translational Research
|
Lexington, MA
|
$205000
|
H-1B1
|
Dec 18, 2024
|
|
BLUEBIRD BIO, INC.
|
DIRECTOR, TRANSLATIONAL BIOMARKERS
|
SOMERVILLE, MA
|
$205000
|
H-1B
|
Mar 22, 2023
|
|
Johns Hopkins University
|
Professor / Assistant Director for Translational …
|
St Petersburg, FL
|
$203600
|
E-3
|
May 24, 2022
|
|
Bristol-Myers Squibb Company
|
Senior Principal Scientist, IPS Translational Epi…
|
Plainsboro, NJ
|
$203374
|
H-1B
|
Feb 24, 2023
|
|
Regeneron Genetics Center, LLC
|
Sr Manager Translational Genetics
|
Tarrytown, NY
|
$200850
|
H-1B
|
Jan 20, 2026
|
|
Mesoblast, Inc.
|
Vice President, Translational Development
|
New York, NY
|
$200000
|
Green Card
|
May 7, 2020
|
|
TRUSTEES OF THE UNIVERSITY OF PENNSYLVA…
|
Senior Director, Translational Research
|
Philadelphia, PA
|
$200000
|
H-1B
|
Dec 4, 2019
|
|
MESOBLAST, INC.
|
VP- TRANSLATIONAL DEVELOPMENT
|
NEW YORK, NY
|
$200000
|
E-3
|
Mar 28, 2018
|
|
MESOBLAST, INC.
|
VP- TRANSLATIONAL DEVELOPMENT
|
NEW YORK, NY
|
$200000
|
E-3
|
Aug 31, 2018
|
|
UPMC Presbyterian Shadyside
|
Director, Translational Sciences
|
Pittsburgh, PA
|
$198000
|
H-1B
|
Dec 26, 2025
|
|
Kymera Therapeutics, Inc.
|
Associate Director, Translational Medicine
|
Watertown, MA
|
$190000
- $215000
|
H-1B
|
Aug 1, 2025
|
|
Bristol-Myers Squibb Company
|
Translational Oncology Program Manager
|
Redwood City, CA
|
$190000
|
H-1B
|
Nov 18, 2020
|
|
Kinnate Biopharma, Inc.
|
Director Translational Medicine
|
San Diego, CA
|
$190000
|
H-1B
|
Sep 9, 2020
|
|
Novo Nordisk Inc.
|
Associate Director, Translational Science
|
Watertown, MA
|
$189000
|
H-1B1
|
Jun 22, 2023
|
|
Regeneron Genetics Center, LLC
|
Manager Translational Genetics
|
Tarrytown, NY
|
$185000
|
H-1B
|
Mar 6, 2026
|
|
Regeneron Genetics Center, LLC
|
Manager Translational Genetics
|
Tarrytown, NY
|
$185000
|
H-1B
|
May 21, 2026
|
|
Eli Lilly and Company
|
Sr. Advisor Process Translation and Execution
|
Indianapolis, IN
|
$185000
|
H-1B
|
Nov 11, 2025
|
|
Inhibrx Inc.
|
Associate Director, Translational and Clinical Ph…
|
La Jolla, CA
|
$184000
|
H-1B
|
Jun 9, 2021
|
|
Regeneron Genetics Center, LLC
|
Sr. Manager Translational Genetics
|
Tarrytown, NY
|
$183180
|
H-1B
|
Apr 24, 2025
|
|
Astellas Pharma Global Development, Inc.
|
Director, Translational Bioinformatics
|
Belmont, MA
|
$182300
- $243000
|
H-1B
|
Sep 12, 2023
|
|
UPMC Presbyterian Shadyside
|
Director, Translational Sciences
|
|
$180000
|
Green Card
|
May 19, 2025
|
|
UPMC Presbyterian Shadyside
|
Director, Translational Sciences
|
Pittsburgh, PA
|
$180000
|
H-1B
|
May 25, 2023
|
|
Orionis Biosciences Inc.
|
Director, Translational Biology
|
Waltham, MA
|
$180000
- $220000
|
H-1B
|
Oct 31, 2022
|
|
Forma Therapeutics, Inc.
|
Associate Director, Translational Science
|
Watertown, MA
|
$180000
|
H-1B1
|
May 26, 2022
|
|
UPMC Presbyterian Shadyside
|
Director, Administration Translational Sciences
|
Pittsburgh, PA
|
$180000
|
H-1B
|
Mar 6, 2020
|
|
UPMC Presbyterian Shadyside
|
Director, Administration Translational Sciences
|
Pittsburgh, PA
|
$180000
|
H-1B
|
Mar 5, 2020
|
|
KINIKSA PHARMACEUTICALS CORP
|
Associate Director, Translational Biology
|
WELLESLEY HILLS, MA
|
$179192
|
Green Card
|
Mar 20, 2017
|
|
Creyon Bio, Inc.
|
Director Translational Medicine
|
Durham, NC
|
$178500
- $241500
|
H-1B
|
Sep 26, 2024
|
|
Creyon Bio, Inc.
|
Director Translational Medicine
|
Durham, NC
|
$178500
- $241500
|
H-1B
|
Sep 26, 2024
|
|
Creyon Bio, Inc.
|
Director Translational Medicine
|
Carlsbad, CA
|
$178500
- $241500
|
H-1B
|
Sep 11, 2024
|